By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Equasens S.A.

Equasens S.A. (0R9T.L)

LSE Market Data in EUR, Fundamentals in GBP
€50.40
-€1.50
-2.89%
Last Update: 17 Jul 2025, 07:06
€757.58M
Market Cap
0.00
P/E Ratio (TTM)
2.48%
Forward Dividend Yield
€46.50 - €85.60
52 Week Range

0R9T.L Stock Price Chart

Explore Equasens S.A. interactive price chart. Choose custom timeframes to analyze 0R9T.L price movements and trends.

There is nothing to show.

0R9T.L Company Profile

Discover essential business fundamentals and corporate details for Equasens S.A. (0R9T.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Equipment & Services

IPO Date

3 Jan 2014

Employees

1.27K

CEO

Grégoire De Rotalier

Description

Equasens Société anonyme provides various IT solutions for the healthcare sector in Europe. It offers LGPI global services and OffiCentral solutions for managing pharmacies and their networks; OffiMSS, OffiSecure, OffiProtect, OffiPass, OffiSeen, OffiCash, Offizzy, and OffiLocker solutions for pharmacists' business processes; and solutions for energizing the customer relationship with pharmacists comprising OffiTag, OffiTouch, OffiMédia, OffiConnect, automation systems, and customer loyalty programs. The company also provides My Pilot, an analytics and management tool; OffiLearning, an e-learning tool; and solutions for patient support and advice, such as compliance monitoring software, Multimeds, Automeds, and OffiTéléconsult, as well as pharmaceutical record and shared medical record services. In addition, it offers a ULTIMATE, a system combining optimized pharmacy management and improved patient support; FARMACLICK, a protocol for communications between pharmacies and wholesalers-distributors; DIFARM, a solution for wholesalers-distributors; PHARE, a retail management tool; SOPHIA, a pharmacy management application; OffiMédia POS display; eNephro to enhance the care of chronic renal failure patients; and TPE Pilot, a web-based application that simplifies the management and sharing of patient education programs. Further, the company provides NOVIACARE; CARELIB Domicile; CARELIB EHPAD; KAPELSE solutions; TITAN solutions; ANTHADINE software and MOBISOINS mobile tool; MICROSOINS, an in-home nursing care solution; and LOGICLIC. Additionally, it offers AXIGATE solutions to manage the entire patient care pathway; CHORUS platform; medical telesecretarial services for healthcare professionals; and equipment lease financing solutions. The company was incorporated in 1996 and is based in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.

0R9T.L Financial Timeline

Browse a chronological timeline of Equasens S.A. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 25 Mar 2026

Upcoming earnings on 26 Sept 2025

Dividend declared on 2 Jul 2025

A dividend of €1.25 per share was announced, adjusted to €1.25. The dividend was paid on 4 Jul 2025.

Earnings released on 28 Mar 2025

EPS came in at €1.51, while revenue for the quarter reached €131.47M.

Earnings released on 7 Nov 2024

EPS came in at €1.35, while revenue for the quarter reached €127.11M, beating expectations by +112.91%.

Dividend declared on 2 Jul 2024

A dividend of €1.25 per share was announced, adjusted to €1.25. The dividend was paid on 4 Jul 2024.

Earnings released on 29 Mar 2024

EPS came in at €1.90, while revenue for the quarter reached €123.09M.

Dividend declared on 3 Jul 2023

A dividend of €1.15 per share was announced, adjusted to €1.15. The dividend was paid on 5 Jul 2023.

Earnings released on 30 Jun 2023

EPS came in at €1.68, while revenue for the quarter reached €130.76M, beating expectations by +16.13%.

Earnings released on 31 Dec 2022

EPS came in at €1.98, while revenue for the quarter reached €126.08M, beating expectations by +14.10%.

Earnings released on 30 Jun 2022

EPS came in at €1.51, while revenue for the quarter reached €120.15K, beating expectations by +15.97%.

Dividend declared on 30 Jun 2022

A dividend of €1.05 per share was announced, adjusted to €1.05. The dividend was paid on 4 Jul 2022.

Earnings released on 31 Dec 2021

EPS came in at €1.77, while revenue for the quarter reached €117.97K.

Dividend declared on 1 Jul 2021

A dividend of €0.95 per share was announced, adjusted to €0.95. The dividend was paid on 5 Jul 2021.

Earnings released on 30 Jun 2021

EPS came in at €1.27, while revenue for the quarter reached €109.29K.

Earnings released on 31 Dec 2020

EPS came in at €1.32, while revenue for the quarter reached €104.29K.

0R9T.L Stock Performance

Access detailed 0R9T.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
0R9T.L
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
0R9T.L
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More